mild Hyperbaric for Long Covid & Chronic Fatigue
“A trial that followed the gold standard of modern medical research—a randomized, placebo-controlled, double-blind design—assigned 73 Long COVID patients to either receive 40 sessions of HBOT or a placebo of only 21% oxygen. The study observed positive changes in attention, sleep quality, pain symptoms, and energy levels among participants receiving HBOT. In a longitudinal follow-up study published in Scientific Reports, the authors at the Tel Aviv University found that clinical improvements persisted even one year after the last HBOT session was concluded. In a second study, the same authors focused on heart function, measured by an echocardiogram, and found a significant reduction in heart strain, known as global longitudinal strain, in patients who received HBOT.”
Long Covid dispatches from the front line with Lisa Sanders MD
Anti-Aging
Alzheimers
HBOT reduces hippocampal damage
Brain Injury
HBOT in traumatic brain injury
HBOT treatment of neurologically impaired
HBOT for neurological dysfunction
Cancer
New strategy for attacking brain tumors
Cancer radiation study abstracts
Hyperbaric does NOT potentially “spread” some cancers
Stroke
HBOT for neurological dysfunction
Parkinsons
Autism / ADD
Hyperbaric Oxygen Report Michael - Autism
Dr.Rossignol HBOT Improves symptoms
in Autistic Children
HBOT treatment for Autism
Lessons from Hopson Quadruplets Autism
Diabetes
Studies / resources diabetes HBOT
HBOT efficacy for diabetic autonomic neuropathy
Multiple Sclerosis
Prostate Cancer
Rheumatoid Diseases
Lyme
HBOT treatment for chronic Lyme
Long Covid
ABC news Hyperbaric & Long Covid